Array › Array

Drugs.com - New Drug Approvals

Thu, 2009-11-12 16:25 — sciencestaff

Reports of FDA and international regulatory bodies' approvals of drugs currently in development.

U.S. Food and Drug Administration Approves Abilify (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
Pfizer Receives FDA Approval For Geodon (Ziprasidone HCl) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
FDA Approves Intravenous Formulation Of Pfizer's Revatio (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
NeurogesX Receives FDA Approval of Qutenza (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)
Xanodyne Announces FDA Approval of Lysteda (Tranexamic Acid) for Treatment of Women with Heavy Menstrual Bleeding
FDA Expands Approved Use of H1N1 Vaccines to Include Infants and Children
FDA Approves Labeling Update for Reyataz (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients
FDA Approves Gloucester Pharmaceuticals' Istodax for Patients with Cutaneous T-cell Lymphoma
FDA Approves Pennsaid Topical Solution
Byetta Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
FDA Approves Arzerra (ofatumumab) for Chronic Lymphocytic Leukemia
FDA Approves Colcrys (colchicine, USP) for Prevention of Gout Flares
FDA Approves GlaxoSmithKline’s Votrient for Advanced Renal Cell Cancer
FDA Approves Twynsta (telmisartan/amlodipine) for Hypertension
FDA Approves New Use for Micardis in Cardiovascular Risk Reduction
FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use
Talecris Biotherapeutics Receives FDA Approval for Prolastin-C
FDA Approves Elitek (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
FDA Approves Gardasil for Use in Boys and Young Men
FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine

More on Sciencestage.com